Home

HT in vitro, target specification, molecule design, hit validation, in vitro screening, in vivo, preclinilcal models, clinical trial, animal research,  preklinikai, tumor, tumor kísérlet, metasztázis, tüdő tumor, rák, rák gyógyítása, kísérlet, klinikai kísérlet, gyógyszer, gyógyszer teszt,

New compounds give a new hope!

 

Given the still dismal overall prognosis for cancer patients, the need is evident to improve the efficacy of novel targeted and personalized anticancer therapies. A therapeutic plateau has been reached with conventional anticancer strategies such as cytotoxic agents, radiotherapy and surgery. In the last few years attention has been focusing, therefore, on the development on new molecularly targeted therapies. However, although targeted anticancer drugs have changed the landscape of the clinical management of malignant tumors, further studies are required to define the precise and optimal role of these agents in the cancer treatment paradigm.

We are specialized to the development of preclinical models for testing various anticancer strategies and treatments.

 

 

All the new compounds successfully tested in preclinical phase
give a new hope for better anticancer treatment.
A therapeutic plateau has been reached with conventional anticancer strategies such as cytotoxic agents, radiotherapy and surgery. In the last few years attention has been focusing, therefore, on the development on new molecularly targeted therapies. However, although targeted anticancer drugs have changed the landscape of the clinical management of malignant tumors, further studies are required to define the precise and optimal role of these agents in the cancer treatment paradigm.

We are specialized in the development of preclinical models for testing various anticancer strategies and treatments.